Harding, M. J., Cantwell, B. M., Milstead, R. A., Harris, A. L., & Kaye, S. B. (1988). Phase II study of the thymidylate synthetase inhibitor CB3717 (N10-propargyl-5,8-dideazafolic acid) in colorectal cancer. Nature Publishing Group.
Styl ChicagoHarding, M. J., B. M. Cantwell, R. A. Milstead, A. L. Harris, a S. B. Kaye. Phase II Study of the Thymidylate Synthetase Inhibitor CB3717 (N10-propargyl-5,8-dideazafolic Acid) in Colorectal Cancer. Nature Publishing Group, 1988.
Citace podle MLAHarding, M. J., et al. Phase II Study of the Thymidylate Synthetase Inhibitor CB3717 (N10-propargyl-5,8-dideazafolic Acid) in Colorectal Cancer. Nature Publishing Group, 1988.
Upozornění: Tyto citace jsou generovány automaticky. Nemusí být zcela správně podle citačních pravidel..